These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR. J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208 [Abstract] [Full Text] [Related]
8. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication. Van Scoy S, Watakabe I, Krainer AR, Hearing J. Virology; 2000 Sep 15; 275(1):145-57. PubMed ID: 11017796 [Abstract] [Full Text] [Related]
9. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes. McClain K, Estrov Z, Raju U, Kelley PK, Aggarwal BB. Methods; 1997 Jan 15; 11(1):83-7. PubMed ID: 8990093 [Abstract] [Full Text] [Related]
10. [Studies on transforming functions of Epstein-Barr virus-specific proteins]. Kinoshita T. Hokkaido Igaku Zasshi; 1990 Jul 15; 65(4):362-75. PubMed ID: 2172130 [Abstract] [Full Text] [Related]
12. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD, Rowe M, Rickinson AB. J Gen Virol; 1990 Jul 15; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [Abstract] [Full Text] [Related]
13. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ, Crawford DH, Thomas JA. J Gen Virol; 1993 Mar 15; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [Abstract] [Full Text] [Related]
14. Epstein-Barr virus: exploiting the immune system. Thorley-Lawson DA. Nat Rev Immunol; 2001 Oct 15; 1(1):75-82. PubMed ID: 11905817 [Abstract] [Full Text] [Related]
15. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40. Crawford DH, Thomas JA, Gregory CD, Catovsky D, Chaggar K. Leukemia; 1995 May 15; 9(5):747-53. PubMed ID: 7539512 [Abstract] [Full Text] [Related]
16. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP. Transplantation; 1994 Aug 15; 58(3):317-24. PubMed ID: 8053055 [Abstract] [Full Text] [Related]
17. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. Klein G, Klein E, Kashuba E. Biochem Biophys Res Commun; 2010 May 21; 396(1):67-73. PubMed ID: 20494113 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Kurth J, Hansmann ML, Rajewsky K, Küppers R. Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4730-5. PubMed ID: 12665622 [Abstract] [Full Text] [Related]
19. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Nilsson T, Sjöblom A, Masucci MG, Rymo L. Virology; 1993 Apr 15; 193(2):774-85. PubMed ID: 8384755 [Abstract] [Full Text] [Related]
20. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. Rooney C, Howe JG, Speck SH, Miller G. J Virol; 1989 Apr 15; 63(4):1531-9. PubMed ID: 2538644 [Abstract] [Full Text] [Related] Page: [Next] [New Search]